Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine.
作者信息
Hlaca Nika, Zagar Tina, Kastelan Marija, Peternel Sandra, Brajac Ines, Dujmovic-Hasanbegovic Katarina, Prpic-Massari Larisa
机构信息
Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
出版信息
Dermatol Ther. 2022 Nov;35(11):e15791. doi: 10.1111/dth.15791. Epub 2022 Sep 7.
Abstract
摘要
相似文献
1
Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine.辉瑞-BioNTech mRNA新冠疫苗加强针接种后出现毛发红糠疹。
Dermatol Ther. 2022 Nov;35(11):e15791. doi: 10.1111/dth.15791. Epub 2022 Sep 7.
2
Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.接种 BNT163b2（辉瑞-生物科技）mRNA COVID-19 疫苗后出现似红糠疹样疹发。
Clin Exp Dermatol. 2022 Jan;47(1):188-190. doi: 10.1111/ced.14878. Epub 2021 Sep 24.
3
Comment on: 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'.关于《mRNA新冠疫苗接种后出现毛发红糠疹样皮疹》的评论
Clin Exp Dermatol. 2022 Jun;47(6):1195-1196. doi: 10.1111/ced.15150. Epub 2022 Mar 26.
4
Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'.关于“新型冠状病毒mRNA疫苗接种后出现毛发红糠疹样皮疹”的评论
Clin Exp Dermatol. 2023 Jan 20;48(1):44-45. doi: 10.1093/ced/llac012.
5
[Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?].[新冠病毒疫苗接种后红皮病型毛发红糠疹：因果关系还是巧合？]
Dermatologie (Heidelb). 2022 Aug;73(8):634-637. doi: 10.1007/s00105-022-04972-z. Epub 2022 Mar 16.
6
Response to "An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris".
Int J Risk Saf Med. 2022;33(3):333. doi: 10.3233/JRS-220010.
7
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.急性发热性嗜中性皮病、毛发红糠疹、急性痘疮样苔藓样糠疹和多形红斑的突然发作：揭示一个可能的共同触发因素——新冠疫苗。
Clin Exp Dermatol. 2022 Feb;47(2):437-440. doi: 10.1111/ced.14970. Epub 2021 Oct 21.
8
Pityriasis rubra pilaris following inactivated SARS-CoV-2 vaccine (CoronaVac).
J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e287-e288. doi: 10.1111/jdv.18768. Epub 2022 Dec 12.
9
Comment on "Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination".
Cutis. 2024 Aug;114(2):46. doi: 10.12788/cutis.1072.
10
Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.接种BNT162b2 mRNA新冠疫苗后发生的（I型）红皮病型毛发红糠疹：使用乌司奴单抗和阿维A成功治疗
Dermatol Ther. 2022 Dec;35(12):e15899. doi: 10.1111/dth.15899. Epub 2022 Oct 11.
引用本文的文献
1
Pityriasis following COVID-19 vaccinations: a systematic review.新冠病毒疫苗接种后的糠疹：一项系统综述
Dermatol Reports. 2023 Aug 9;16(1):9742. doi: 10.4081/dr.2023.9742. eCollection 2024 Mar 12.
2
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.红癣：临床特征、发病机制及治疗选择的最新综述。
Am J Clin Dermatol. 2024 Mar;25(2):243-259. doi: 10.1007/s40257-023-00836-x. Epub 2023 Dec 30.
3
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
4
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
Zotero 插件